AZN vs PBH · P/E 28, $288.38B cap vs P/E 19, rev $1.09B
AstraZeneca PLC (AZN) versus Prestige Brand Holdings Inc (PBH) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Prestige Brand Holdings Inc (PBH) is a drug manufacturers - specialty & generic company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported PBH revenue for 2026-03-31 was $1.09B. Net income was $190.3M. Revenue was down 4.3% from 2025-03-31 to 2026-03-31. PBH currently screens at market cap $4.00B and trailing P/E 18.9.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. PBH currently screens at market cap $4.00B and trailing P/E 18.9.
Not investment advice. Open the AZN and PBH stock pages for the full models.
Not investment advice.